Viewing Study NCT00819234


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-31 @ 3:51 PM
Study NCT ID: NCT00819234
Status: COMPLETED
Last Update Posted: 2015-04-15
First Post: 2008-12-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leptin View
None Pramlintide View
None Obese View
None Symlin View
None Amylin View